Search Results - "KUNNE, Cindy"

Refine Results
  1. 1
  2. 2

    Direct Intestinal Cholesterol Secretion Contributes Significantly to Total Fecal Neutral Sterol Excretion in Mice by van der Velde, Astrid E, Vrins, Carlos L.J, van den Oever, Karin, Kunne, Cindy, Oude Elferink, Ronald P.J, Kuipers, Folkert, Groen, Albert K

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2007)
    “…Background & Aims: Hepatobiliary secretion is generally believed to be an integral step in the pathway of cholesterol excretion from the body. Here we have…”
    Get full text
    Journal Article
  3. 3

    Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis by Duijvis, Nicolette W, Moerland, Perry D, Kunne, Cindy, Slaman, Monique M W, van Dooren, Faas H, Vogels, Esther W, de Jonge, Wouter J, Meijer, Sybren L, Fluiter, Kees, Te Velde, Anje A

    Published in PloS one (23-10-2017)
    “…MicroRNAs (miRNAs) are epigenetically involved in regulating gene expression. They may be of importance in the pathogenesis of inflammatory bowel disease…”
    Get full text
    Journal Article
  4. 4

    Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease by Gaemers, Ingrid C., Stallen, Jan M., Kunne, Cindy, Wallner, Christian, van Werven, Jochem, Nederveen, Aart, Lamers, Wouter H.

    Published in Biochimica et biophysica acta (01-04-2011)
    “…The major risk factors for non-alcoholic fatty liver disease (NAFLD) are obesity, insulin resistance and dyslipidemia. The cause for progression from the…”
    Get full text
    Journal Article
  5. 5

    Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein by de Waart, Dirk R, Häusler, Stephanie, Vlaming, Maria L H, Kunne, Cindy, Hänggi, Emanuel, Gruss, Hans-Jurgen, Oude Elferink, Ronald P J, Stieger, Bruno

    “…Cholyl-L-lysyl-fluorescein (CLF) is a fluorescent bile salt derivative that is being developed as an agent for determining in vivo liver function. However, the…”
    Get more information
    Journal Article
  6. 6

    Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content by Paulusma, Coen C., de Waart, D.Rudi, Kunne, Cindy, Mok, Kam S., Elferink, Ronald P.J.Oude

    Published in The Journal of biological chemistry (10-04-2009)
    “…Mutations in ATP8B1 cause severe inherited liver disease. The disease is characterized by impaired biliary bile salt excretion (cholestasis), but the mechanism…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Oral availability of cefadroxil depends on ABCC3 and ABCC4 by de Waart, Dirk R, van de Wetering, Koen, Kunne, Cindy, Duijst, Suzanne, Paulusma, Coen C, Oude Elferink, Ronald P J

    Published in Drug metabolism and disposition (01-03-2012)
    “…Some cephalosporins, such as cefadroxil, are orally available. H(+)-coupled peptide transporter 1 mediates the transport of cephalosporins across the apical…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis by Kunne, Cindy, de Graaff, Marijke, Duijst, Suzanne, de Waart, Dirk R, Oude Elferink, Ronald P J, Paulusma, Coen C

    Published in Laboratory investigation (01-10-2014)
    “…Progressive familial intrahepatic cholestasis (PFIC) types 1 and 3 are severe cholestatic liver diseases caused by deficiency of ATB8B1 and ABCB4,…”
    Get full text
    Journal Article
  11. 11

    Complex Pharmacokinetic Behavior of Ezetimibe Depends on Abcc2, Abcc3, and Abcg2 by DE WAART, Dirk R, VLAMING, Maria L. H, KUNNE, Cindy, SCHINKEL, Alfred H, OUDE ELFERINK, Ronald P. J

    Published in Drug metabolism and disposition (01-08-2009)
    “…Ezetimibe lowers plasma cholesterol levels by inhibiting the uptake of cholesterol in the intestine. Because of the extensive enterohepatic circulation of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A PYRUVATE-BUFFERED DIALYSIS FLUID INDUCES LESS PERITONEAL ANGIOGENESIS AND FIBROSIS THAN A CONVENTIONAL SOLUTION by van Westrhenen, Roos, Zweers, Machteld M, Kunne, Cindy, de Waart, Dirk R, van der Wal, Allard C, Krediet, Raymond T

    Published in Peritoneal dialysis international (01-09-2008)
    “…Division of Nephrology, 1 Department of Medicine; Department of Experimental Hepatology 2 and Department of Cardiovascular Pathology, 3 Academic Medical…”
    Get full text
    Journal Article
  14. 14

    Multidrug resistance associated protein 2 mediates transport of prostaglandin E2 by De Waart, Dirk R., Paulusma, Coen C., Kunne, Cindy, Oude Elferink, Ronald P. J.

    Published in Liver international (01-04-2006)
    “…: Background/Aim: Inactivation of prostaglandin E2 (PGE2) in the liver is a rapid process and occurs mainly through β‐oxidation in the peroxisome of the…”
    Get full text
    Journal Article
  15. 15

    Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8 by KOSTERS, Astrid, FRIJTERS, Raoul J. J. M, KUNNE, Cindy, VINK, Edwin, SCHNEIDERS, Marit S, SCHAAP, Frank G, NIBBERING, Catherina P, FATEL, Shailendra B, GROEN, Albert K

    Published in Hepatology (Baltimore, Md.) (2005)
    “…The plant sterol diosgenin has been shown to stimulate biliary cholesterol secretion in mice without affecting the expression of the adenosine…”
    Get full text
    Journal Article
  16. 16

    The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice1 by Kosters, Astrid, Kunne, Cindy, Looije, Norbert, Patel, Shailendra B., Oude Elferink, Ronald P.J., Groen, Albert K.

    Published in Journal of lipid research (01-09-2006)
    “…The main player in biliary cholesterol secretion is the heterodimeric transporter complex, ABCG5/ABCG8, the function of which is necessary for the majority of…”
    Get full text
    Journal Article
  17. 17

    Actual Usage and Quality of Experimental Colitis Models in Preclinical Efficacy Testing: A Scoping Review by Zeeff, Sophia B, Kunne, Cindy, Bouma, Gerd, de Vries, Rob B, Te Velde, Anje A

    Published in Inflammatory bowel diseases (01-06-2016)
    “…There is no standardized validated experimental model used to predict human drug response, and the choice of model is not based on systematic evidence…”
    Get full text
    Journal Article
  18. 18

    FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model by Kunne, Cindy, Acco, Alexandra, Duijst, Suzanne, de Waart, Dirk R., Paulusma, Coen C., Gaemers, Ingrid, Oude Elferink, Ronald P.J.

    Published in Biochimica et biophysica acta (01-05-2014)
    “…It has been established that bile salts play a role in the regulation of hepatic lipid metabolism. Accordingly, overt signs of steatosis have been observed in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity by Kunne, Cindy, Acco, Alexandra, Hohenester, Simon, Duijst, Suzanne, de Waart, Dirk R., Zamanbin, Alaleh, Oude Elferink, Ronald P.J.

    Published in Hepatology (Baltimore, Md.) (01-04-2013)
    “…The difference in bile salt (BS) composition between rodents and humans is mainly caused by formation of muricholate in rodents as well as by efficient…”
    Get full text
    Journal Article